---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-099878"
form_type: "8-K"
ticker: "AMRN"
cik: "0000897448"
company_name: "AMARIN CORP PLCUK"
filed_at: "2025-07-30T23:59:59+00:00"
generated_at: "2026-05-17T23:25:47.732362+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Amarin Q2 net loss $14.1M; signs European licensing deal with Recordati, plans restructuring

## Summary
- Q2 net loss of $14.1M ($0.03 per share) vs. $1.5M net income in Q2 2024.
- Total net revenue $72.7M (+8% YoY); licensing revenue up 31% on Recordati upfront.
- Signed exclusive European licensing agreement with Recordati for VAZKEPA in 59 countries.
- Global restructuring expected to deliver $70M in operating expense savings over 12 months.
- Cash $298.7M, debt-free; U.S. product revenue down 17% to $36.5M, Europe up 85% to $6.6M.

## SEC filing metadata
- accession: 0000950170-25-099878
- form_type: 8-K
- ticker: AMRN
- cik: 0000897448
- company_name: AMARIN CORP PLCUK
- filed_at: 2025-07-30T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/897448/000095017025099878/0000950170-25-099878-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/897448/000095017025099878/amrn-20250730.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-099878
- JSON: https://secwatch.observer/filing/0000950170-25-099878.json
- Plain text: https://secwatch.observer/filing/0000950170-25-099878.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.